BrightSpring Health Services Inc (BTSG) concluded trading on Wednesday at a closing price of $21.89, with 7.08 million shares of worth about $154.99 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 19.75% during that period and on June 11, 2025 the price saw a loss of about -1.57%. Currently the company’s common shares owned by public are about 175.18M shares, out of which, 78.65M shares are available for trading.
Stock saw a price change of -7.17% in past 5 days and over the past one month there was a price change of -2.06%. Year-to-date (YTD), BTSG shares are showing a performance of 28.54% which increased to 99.91% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.15 but also hit the highest price of $25.57 during that period. The average intraday trading volume for BrightSpring Health Services Inc shares is 1.90 million. The stock is currently trading -6.91% below its 20-day simple moving average (SMA20), while that difference is up 6.80% for SMA50 and it goes to 19.37% higher than SMA200.
BrightSpring Health Services Inc (NASDAQ: BTSG) currently have 175.18M outstanding shares and institutions hold larger chunk of about 52.71% of that.
The stock has a current market capitalization of $3.85B and its 3Y-monthly beta is at 2.55. PE ratio of stock for trailing 12 months is 77.79, while it has posted earnings per share of $0.28 in the same period. Its PEG reads 2.73 and has Quick Ratio of 1.37 while making debt-to-equity ratio of 1.61. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BTSG, volatility over the week remained 3.96% while standing at 2.19% over the month.
Stock’s fiscal year EPS is expected to rise by 51.53% while it is estimated to increase by 20.46% in next year. EPS is likely to shrink at an annualized rate of 28.45% for next 5-years, compared to annual growth of 60.10% made by the stock over the past 5-years.
On June 21, 2024, BTIG Research Initiated their recommendations, while on March 06, 2024, HSBC Securities Initiated their ratings for the stock with a price target of $13. Stock get a Buy rating from Deutsche Bank on February 27, 2024.
